Effectiveness of the Henna Application in Patients with Hand-Foot Syndrome: Nested Case-Control Study

CompletedOBSERVATIONAL
Enrollment

84

Participants

Timeline

Start Date

October 15, 2018

Primary Completion Date

December 15, 2018

Study Completion Date

December 31, 2019

Conditions
HennaHand-Foot SyndromeCase-Control Study
Interventions
OTHER

Henna

The day-care unit of the University of Hacettepe's oncology hospital is being trained by educational nurses on the treatment of patients receiving capecitabine a day before the application of chemotherapy. All the patients were questioned about their individual and disease-related characteristics using the Patient Information Form, and The National Cancer Institute common terminology criteria for adverse events - version 4.03 (NCICTCAE v4.03), EORTC C30 Cancer Quality of Life Scale, and The Hand-Foot Syndrome-14 (HFS-14) were used by face-to-face interview technique.On the 21st day and the 63rd day after the first treatment course, patients who developed hand-foot syndrome constituted the case-control group, including patients who applied henna and patients who did not apply henna.

Trial Locations (1)

06100

Hacettepe University, Ankara

All Listed Sponsors
lead

Hacettepe University

OTHER

NCT06832501 - Effectiveness of the Henna Application in Patients with Hand-Foot Syndrome: Nested Case-Control Study | Biotech Hunter | Biotech Hunter